Browsing by Author "Ferrer, Joana"

Sort by: Order: Results:

  • Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study
    Posso, Margarita; Corominas Torres, Josep Maria; Serrano, Laia; Román, Marta; Torá Rocamora, Isabel, 1979-; Domingo, Laia; Romero, Anabel; Quintana, María Jesús; Vernet-Tomás, Maria; Baré, Marisa; Vidal, Carmen; Sánchez, Mar; Saladié, Francina; Natal, Carmen; Ferrer, Joana; Servitja Tormo, Sonia; Sala, Maria; Castells, Xavier; BELE Study Group (Wiley, 2017)
    Women with benign breast diseases (BBD) have a high risk of breast cancer. However, no biomarkers have been clearly established to predict cancer in these women. Our aim was to explore whether estrogen receptor (ER), ...
  • Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain
    Román, Marta; Caicoya, Martin; Espinàs, Josep Alfons; Sala Serra, Maria; Torá Rocamora, Isabel, 1979-; Quinta, Maria J.; Vernet-Tomás, Maria; Saladié, Francina; Romero, Anabel; Sánchez, Mar; Baré, Marisa; Vidal, Carmen; Servitja Tormo, Sonia; Natal, Carmen; Corominas Torres, Josep Maria; Ferrer, Joana; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Wiley-Blackwell, 2018)
    Women with a benign breast disease (BBD) have an increased risk of subsequent breast carcinoma. Information is scarce regarding the characteristics of breast carcinomas diagnosed after a BBD. Our aim was to point out the ...
  • Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening
    Román, Marta; Quintana, María Jesús; Ferrer, Joana; Sala Serra, Maria; Castells, Xavier (Nature Publishing Group, 2017)
    BACKGROUND: Our aim was to assess the cumulative risk of false-positive screening results, screen-detected cancer, and interval breast cancer in mammography screening among women with and without a previous benign breast ...
  • Differences in breast cancer risk after benign breast disease by type of screening diagnosis
    Louro, Javier; Román, Marta; Posso, Margarita; Comerma Blesa, Laura, 1983-; Vidal, Carmen; Saladié, Francina; Alcántara da Silva, Rodrigo; Sánchez, Mar; Quintana, María Jesús; Del Riego, Javier; Ferrer, Joana; Peñalva, Lupe; Bargalló Castelló, Xavier; Prieto, Miguel; Sala Serra, Maria; Castells, Xavier (Elsevier, 2020)
    Introduction: We aimed to assess differences in breast cancer risk across benign breast disease diagnosed at prevalent or incident screens. Materials and methods: We conducted a retrospective cohort study with data from ...
  • Exploring the role of breast density on cancer prognosis among women attending population-based screening programmes
    Domingo Torrell, Laia; Sala Serra, Maria; Louro, Javier; Baré, Marisa; Barata, Teresa; Ferrer, Joana; Carmona-Garcia, Maria Carmen; Comas Serrano, Mercè; Castells, Xavier; CAMISS Study Group (Hindawi, 2019)
    Background: Our aim was to assess the role of breast density on breast cancer mortality and recurrences, considering patient and tumour characteristics and the treatments received among women attending population-based ...
  • Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study
    Miret, Carme; Domingo, Laia; Louro, Javier; Barata, Teresa; Baré, Marisa; Ferrer, Joana; Carmona-Garcia, Maria Carmen; Castells, Xavier; Sala, Maria (BioMed Central, 2019)
    Background: We aimed to identify the risk factors associated with early, late and long-term readmissions in women diagnosed with breast cancer participating in screening programs. Methods: We performed a multicenter cohort ...
  • Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré, Marisa; Torà, Núria; Sala, Dolors, 1967-; Sentís, Melchor; Ferrer, Joana; Ibáñez, Josefa; Zubizarreta, Raquel; Sarriugarte, Garbiñe; Barata, Teresa; Domingo, Laia; Castells, Xavier; Sala, Maria; INCA STUDY GROUP (Springer Verlag, 2015)
    In the context of a population-based screening program, we aimed to evaluate the major mammographic features and clinicopathological characteristics of breast tumors at diagnosis and the associations between them, focusing ...
  • Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs.
    Romero, Anabel; Torá Rocamora, Isabel, 1979-; Baré, Marisa; Barata, Teresa; Domingo, Laia; Ferrer, Joana; Torà, Núria; Comas Serrano, Mercè; Merenciano, Carmen; Macià Guilà, Francesc Assís; Castells, Xavier; Sala, Maria; CAMISS Study Group (BioMed Central, 2016)
    BACKGROUND: To date, the study of the risks and benefits of breast cancer screening has not included the onset of persistent pain after breast cancer treatment within the context of population-based screening programs. Our ...
  • Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall
    Vernet-Tomás, Maria; Louro, Javier; Román, Marta; Saladié, Francina; Posso, Margarita; Prieto, Miguel; Vázquez, Ivonne; Baré, Marisa; Peñalva, Lupe; Vidal, Carmen; Bargalló Castelló, Xavier; Sánchez, Mar; Ferrer, Joana; Espinàs, Josep Alfons; Quintana, María Jesús; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Elsevier, 2021)
    Objective: We aimed to explore whether the type of mammographic feature prompting a false-positive recall (FPR) during mammography screening influences the risk and timing of breast cancer diagnosis, particularly if assessed ...
  • Survival and disease-free survival by breast density and fhenotype in interval breast cancers
    Sala Serra, Maria; Domingo, Laia; Louro, Javier; Torá Rocamora, Isabel, 1979-; Baré, Marisa; Ferrer, Joana; Carmona-Garcia, Maria Carmen; Barata, Teresa; Román, Marta; Macià Guilà, Francesc Assís; Castells, Xavier; CAMISS Study Group (American Association for Cancer Research (AACR), 2018)
    Background: We aimed to evaluate survival and disease-free survival in different subtypes of interval cancers by breast density, taking into account clinical and biological characteristics.Methods: We included 374 invasive ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking